How should oral fosfomycin tromethamine be administered, including dose, preparation, timing, and considerations for renal impairment and pediatric patients?

How to Administer Oral Fosfomycin

Oral fosfomycin tromethamine should be administered as a single 3-gram dose dissolved in 3-4 ounces (½ cup) of cool or room temperature water, taken immediately after dissolving, and can be given with or without food. 1

Standard Adult Dosing

For uncomplicated urinary tract infections (acute cystitis) in women ≥18 years:

• Single dose: 3 grams (one sachet) 1
• Timing: Can be taken with or without food, though food reduces bioavailability from 37% to 30% 1
• Duration: Single dose achieves urinary concentrations >100 mcg/mL for 24-48 hours 1, 2

Preparation Instructions

Critical preparation steps:

• Pour entire sachet contents into 3-4 ounces (½ cup) of water 1
• Do not use hot water 1
• Stir to dissolve completely
• Never take in dry form 1
• Drink immediately after dissolving 1

Renal Impairment Considerations

Dose adjustments are necessary when creatinine clearance is compromised:

• CrCl >50 mL/min: No adjustment needed 3
• CrCl <50 mL/min: Dose modification required due to prolonged half-life (increases from 5.7 hours to 11-50 hours) 1, 3
• Hemodialysis patients: Half-life extends to 40 hours; urinary excretion decreases from 38% to 11% 1
• Anuric patients: Fosfomycin accumulates significantly 1

The evidence shows that in patients with renal insufficiency, serum concentrations (Cmax, AUC) are significantly higher and elimination half-life is prolonged 3. While the FDA label doesn't provide specific dose adjustments for renal impairment, pharmacokinetic data clearly demonstrates the need for caution and likely dose reduction when CrCl falls below 50 mL/min 3.

Pediatric Dosing

For adolescent females (12-17 years) with uncomplicated lower UTIs:

• Dose: 3 grams as single dose 4
• Evidence: Retrospective study of 70 female adolescents (median age 13 years) showed 97% clinical cure and 94% microbiological cure with excellent tolerability 4

For younger children:

• Limited data exists for children <12 years
• One study used 2 grams as single dose in children with lower UTIs, showing 80.2% cure rate 5
• Not routinely recommended in young children due to limited safety and efficacy data

Clinical Considerations

Pharmacokinetic advantages:

• Peak urinary concentrations of 706-4415 mg/L occur within 2-4 hours 1, 2
• Maintains therapeutic urinary levels (>128 mg/L) for 24-48 hours 1, 2
• Not metabolized; excreted unchanged (38% urine, 18% feces) 1
• No plasma protein binding 1

Drug interactions:

• Metoclopramide: Lowers serum concentrations and urinary excretion—avoid concurrent use 1
• Cimetidine: No effect on pharmacokinetics 1

Special populations:

• Elderly: No dose adjustment needed 1
• Pregnancy: Category B; considered safe 2
• Gender: No pharmacokinetic differences 1

Common Pitfalls to Avoid

1. Using hot water for preparation reduces drug stability 1
2. Taking in dry powder form is contraindicated 1
3. Ignoring renal function in patients with CrCl <50 mL/min leads to drug accumulation 3
4. Co-administering with metoclopramide significantly reduces efficacy 1
5. Expecting systemic coverage—fosfomycin achieves high urinary but modest serum concentrations 1